Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients

Pancreaticobiliary Cancer Clinical Trial

Official title:
Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients

Status Completed

Clinical Trial Summary

Decreased bowel function and loss of appetite in patients who underwent pancreaticobiliary surgery contribute impaired nutritional status in postoperative period. It can also affect perioperative and oncologic outcomes negatively. Therefore it is important to improve nutritional status in postoperative period by supply tailor-made optimal diets. The investigators have developed customized postoperative diets and products for pancreaticobiliary cancer patients. The investigators expect that nutritional supplement for pancreaticobiliary patients will increase the food intake rate and contribute a improvement of perioperative outcomes and even oncologic outcomes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Pancreaticobiliary Cancer

Clinical Trial Details

NCT number	NCT03294096
Study type	Interventional
Source	Yonsei University
Contact
Status	Completed
Phase	N/A
Start date	September 4, 2017
Completion date	July 11, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02964806` - Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients	N/A
Not yet recruiting	`NCT05171361` - Pancreaticogastrostomy Versus Pancreaticojejunostomy With Dunking Technique After Pancreaticodudenectomy: A Prospective Randomized Comparative Study
Recruiting	`NCT03510429` - Clinical Validation of Nutritional Supplements("Ketogenic Plus") Developed for Pancreaticobiliary Cancer Patients	N/A